186 related articles for article (PubMed ID: 36658121)
1. PHB2 promotes colorectal cancer cell proliferation and tumorigenesis through NDUFS1-mediated oxidative phosphorylation.
Ren L; Meng L; Gao J; Lu M; Guo C; Li Y; Rong Z; Ye Y
Cell Death Dis; 2023 Jan; 14(1):44. PubMed ID: 36658121
[TBL] [Abstract][Full Text] [Related]
2. PHB2 promotes tumorigenesis
Wu B; Chang N; Xi H; Xiong J; Zhou Y; Wu Y; Wu S; Wang N; Yi H; Song Y; Chen L; Zhang J
Theranostics; 2021; 11(7):3150-3166. PubMed ID: 33537079
[No Abstract] [Full Text] [Related]
3. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis.
Yan C; Gong L; Chen L; Xu M; Abou-Hamdan H; Tang M; Désaubry L; Song Z
Autophagy; 2020 Mar; 16(3):419-434. PubMed ID: 31177901
[TBL] [Abstract][Full Text] [Related]
4. Prohibitin 2/PHB2 in Parkin-Mediated Mitophagy: A Potential Therapeutic Target for Non-Small Cell Lung Carcinoma.
Zhang H; Yin C; Liu X; Bai X; Wang L; Xu H; Ju J; Zhang L
Med Sci Monit; 2020 Apr; 26():e923227. PubMed ID: 32320388
[TBL] [Abstract][Full Text] [Related]
5. Lamprey prohibitin 2 inhibits non-small cell lung carcinoma cell proliferation by down-regulating the expression and phosphorylation levels of cell cycle-associated proteins.
Zhang X; Zhao J; Li Q; Qin D; Li W; Wang X; Bi M; Li Q; Li T
Fish Shellfish Immunol; 2023 Mar; 134():108560. PubMed ID: 36681363
[TBL] [Abstract][Full Text] [Related]
6. PHB2 Maintains the Contractile Phenotype of VSMCs by Counteracting PKM2 Splicing.
Jia Y; Mao C; Ma Z; Huang J; Li W; Ma X; Zhang S; Li M; Yu F; Sun Y; Chen J; Feng J; Zhou Y; Xu Q; Zhao L; Fu Y; Kong W
Circ Res; 2022 Oct; 131(10):807-824. PubMed ID: 36200440
[TBL] [Abstract][Full Text] [Related]
7. Decreasing expression of Prohibitin-2 lowers the oncogenicity of renal cell carcinoma cells by suppressing eIF4E-mediated oncogene translation via MNK inhibition.
Yang J; Li G; Huang Y; Liu Y
Toxicol Appl Pharmacol; 2023 May; 466():116458. PubMed ID: 36931439
[TBL] [Abstract][Full Text] [Related]
8. Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma.
Ellinger J; Poss M; Brüggemann M; Gromes A; Schmidt D; Ellinger N; Tolkach Y; Dietrich D; Kristiansen G; Müller SC
Clin Genitourin Cancer; 2017 Aug; 15(4):e551-e562. PubMed ID: 28063846
[TBL] [Abstract][Full Text] [Related]
9. Broad phenotypic variability in patients with complex I deficiency due to mutations in NDUFS1 and NDUFV1.
Björkman K; Sofou K; Darin N; Holme E; Kollberg G; Asin-Cayuela J; Holmberg Dahle KM; Oldfors A; Moslemi AR; Tulinius M
Mitochondrion; 2015 Mar; 21():33-40. PubMed ID: 25615419
[TBL] [Abstract][Full Text] [Related]
10. Essential Protein PHB2 and Its Regulatory Mechanisms in Cancer.
Qi A; Lamont L; Liu E; Murray SD; Meng X; Yang S
Cells; 2023 Apr; 12(8):. PubMed ID: 37190120
[TBL] [Abstract][Full Text] [Related]
11. The survival and proliferation of osteosarcoma cells are dependent on the mitochondrial BIG3-PHB2 complex formation.
Toki S; Yoshimaru T; Matsushita Y; Aihara H; Ono M; Tsuneyama K; Sairyo K; Katagiri T
Cancer Sci; 2021 Oct; 112(10):4208-4219. PubMed ID: 34363714
[TBL] [Abstract][Full Text] [Related]
12. The role and molecular mechanism of metabolic reprogramming of colorectal cancer by UBR5 through PYK2 regulation of OXPHOS expression study.
Qin R; Huang Y; Yao Y; Wang L; Zhang Z; Huang W; Su Y; Zhang Y; Guan A; Wang H
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23376. PubMed ID: 37098808
[TBL] [Abstract][Full Text] [Related]
13. Prohibitin-2 negatively regulates AKT2 expression to promote prostate cancer cell migration.
Shen Y; Gao Y; Yuan H; Cao J; Jia B; Li M; Peng Y; Du X; Zhang J; Shi J
Int J Mol Med; 2018 Feb; 41(2):1147-1155. PubMed ID: 29207197
[TBL] [Abstract][Full Text] [Related]
14. Prohibitin 2: A key regulator of cell function.
Zhang B; Li W; Cao J; Zhou Y; Yuan X
Life Sci; 2024 Feb; 338():122371. PubMed ID: 38142736
[TBL] [Abstract][Full Text] [Related]
15. The prohibitin protein complex promotes mitochondrial stabilization and cell survival in hematologic malignancies.
Ross JA; Robles-Escajeda E; Oaxaca DM; Padilla DL; Kirken RA
Oncotarget; 2017 Sep; 8(39):65445-65456. PubMed ID: 29029444
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
17. Down regulation of NDUFS1 is involved in the progression of parenteral-nutrition-associated liver disease by increasing Oxidative stress.
Wan S; Maitiabula G; Wang P; Zhang Y; Gao X; Zhang L; Gao T; Wang X
J Nutr Biochem; 2023 Feb; 112():109221. PubMed ID: 36402252
[TBL] [Abstract][Full Text] [Related]
18. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
19. Association of Genes, Pathways, and Haplogroups of the Mitochondrial Genome with the Risk of Colorectal Cancer: The Multiethnic Cohort.
Li Y; Beckman KB; Caberto C; Kazma R; Lum-Jones A; Haiman CA; Le Marchand L; Stram DO; Saxena R; Cheng I
PLoS One; 2015; 10(9):e0136796. PubMed ID: 26340450
[TBL] [Abstract][Full Text] [Related]
20. Leptin promotes fatty acid oxidation and OXPHOS via the c-Myc/PGC-1 pathway in cancer cells.
Liu Q; Sun Y; Fei Z; Yang Z; Duan K; Zi J; Cui Q; Yu M; Xiong W
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):707-714. PubMed ID: 31187140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
